COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,884 Articles (22,568 medRxiv, 8,316 bioRxiv)

Most recent first Previous |  Page 3049: Articles 30481-30490  | Next

Restoration of leukomonocyte counts is associated with viral clearance in COVID-19 hospitalized patients
Chen, X., Ling, J., Mo, P., Zhang, Y., Jiang, Q., Ma, Z., Cao, Q., Hu, W., Zou, S., Chen, L., Yao, L., Luo, M., Chen, T., Deng, L., Liang, K., Song, S., Yang, R., Zheng, R., Gao, S., Gui, X., Ke, H., Hou, W., Lundkvist, A., Xiong, Y.
10.1101/2020.03.03.20030437 — Posted: 2020-03-06 Discussion: Onsite
Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome
Yang, Y., Shen, C., Li, J., Yuan, J., Yang, M., Wang, F., Li, G., Li, Y., Xing, L., Peng, L., Wei, J., Cao, M., Zheng, H., Wu, W., Zou, R., Li, D., Xu, Z., Wang, H., Zhang, M., Zhang, Z., Liu, L., Liu, Y.
10.1101/2020.03.02.20029975 — Posted: 2020-03-06 Discussion: Onsite
Preliminary epidemiological analysis on children and adolescents with novel coronavirus disease 2019 outside Hubei Province in China: an observational study utilizing crowdsourced data
Henry, B. M., Oliveira, M. H. S.
10.1101/2020.03.01.20029884 — Posted: 2020-03-06
Estimation of COVID-19 outbreak size in Italy based on international case exportations
Tuite, A., Ng, V., Rees, E., Fisman, D.
10.1101/2020.03.02.20030049 — Posted: 2020-03-06
The timing of one-shot interventions for epidemic control
Di Lauro, F., Kiss, I. Z., Miller, J.
10.1101/2020.03.02.20030007 — Posted: 2020-03-06
Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak: an observational and modelling study
Lai, S., Ruktanonchai, N. W., Zhou, L., Prosper, O., Luo, W., Floyd, J. R., Wesolowski, A., Zhang, C., Du, X., Yu, H., Tatem, A. J.
10.1101/2020.03.03.20029843 — Posted: 2020-03-06 Discussion: Onsite
Clinical and Laboratory Profiles of 75 Hospitalized Patients with Novel Coronavirus Disease 2019 in Hefei, China
Zhao, Z., Xie, J., Yin, M., Yang, Y., He, H., Jin, T., Li, W., Zhu, X., Xu, J., Zhao, C., Li, L., Li, Y., Mengist, H. M., Zahid, A., Yao, Z., Ding, C., Qi, Y., Gao, Y., Ma, X.
10.1101/2020.03.01.20029785 — Posted: 2020-03-06 Discussion: Onsite
The potential role of IL-6 in monitoring coronavirus disease 2019.
Liu, T., Zhang, J., Yang, Y., Zhang, L., Ma, H., Li, Z., Zhang, J., Cheng, J., Zhang, X., Wu, G., Yi, J.
10.1101/2020.03.01.20029769 — Posted: 2020-03-06 Discussion: Onsite | Offsite
Estimating the burden of United States workers exposed to infection or disease: a key factor in containing risk of COVID-19 infection
Baker, M. G., Peckham, T. K., Seixas, N. S.
10.1101/2020.03.02.20030288 — Posted: 2020-03-06
Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, China
Zhang, G., Hu, C., Luo, L., Fang, F., Chen, Y., Li, J., Peng, Z., Pan, H.
10.1101/2020.03.02.20030452 — Posted: 2020-03-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).